Cyclica

About:

Cyclica is a company that creates patented cloud-based predictive analytics software to find safer and more effective medicines.

Website: http://www.cyclicarx.com

Twitter/X: cyclica

Top Investors: StartUp Health, Bill & Melinda Gates Foundation, GreenSky Ventures, Drive Capital, Chiesi Farmaceutici

Description:

Cyclica is the partner of choice for data-driven drug discovery. The software developed by the company uses biophysics and artificial intelligence (AI) to improve drug discovery practices by generating a list of putative ligand-protein interactions, allowing health institutions to prioritize lead candidates, elucidate adverse effects, and understand repurposing opportunities.

Total Funding Amount:

$25.6M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Toronto, Ontario, Canada

Founded Date:

2013-05-01

Contact Email:

inquiries(AT)cyclicarx.com

Founders:

Jason Mitakidis, Naheed Kurji

Number of Employees:

11-50

Last Funding Date:

2022-11-15

IPO Status:

Private

Industries:

© 2025 bioDAO.ai